← Leaderboards
Angela Jiyeon Yoon
Columbia University Health Sciences
$2,080,255
Attributed
$2,143,632
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $416.5K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,143,632 · 4
By mechanism
R01$1,368,000 · 1
R21$416,544 · 1
R03$240,000 · 1
P30$119,088 · 1
Top collaborators
- Richard Carvajal1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Kenneth L Shepard$17,951,329
- Anil K Rustgi$51,275,906
- Hanina Hibshoosh$4,684,222
- Fatemeh Momen Heravi$6,081,395
- Elizabeth Philipone$240,000
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorResearch PersonnelMalignant NeoplasmsAreaResearch Project GrantsProgramsGrantNewly DiagnosedDiagnosisSelection For TreatmentsPrognosticMissionBaseOperative Surgical ProceduresMolecular ProfilingMicrornasMouth Squamous Cell CarcinomaCancer PatientCessation Of LifeModalityAmericanMalignant Mouth NeoplasmPathologyReporting
Grant awards (10)
Biorepository & Tissue Analysis Shared Resource$61,276
P30 · FY2025 · CA · contact PI
Biorepository & Tissue Analysis Shared Resource$57,812
P30 · FY2024 · CA · contact PI
Exploratory clinical trial of topical Imiquimod 5% cream as window-of-opportunity monotherapy for early-stage oral cancer$289,789
R21 · FY2021 · CA · contact PI
Exploratory clinical trial of topical Imiquimod 5% cream as window-of-opportunity monotherapy for early-stage oral cancer$126,755
R21 · FY2021 · CA · contact PI
MicroRNA-based prognostic model for early-stage oral cancer patients$342,000
R01 · FY2020 · DE · contact PI
MicroRNA-based prognostic model for early-stage oral cancer patients$342,000
R01 · FY2019 · DE · contact PI
MicroRNA-based prognostic model for early-stage oral cancer patients$342,000
R01 · FY2018 · DE · contact PI
MicroRNA-based prognostic model for early-stage oral cancer patients$342,000
R01 · FY2017 · DE · contact PI
MicroRNA marker-based prognosis of oral cancer survival$120,000
R03 · FY2014 · DE · contact PI
MicroRNA marker-based prognosis of oral cancer survival$120,000
R03 · FY2013 · DE · contact PI